CRH Medical reports issuance of stock options

VANCOUVER , Dec. 11 /CNW/ - CRH Medical Corporation (CRM:TSX-V) announced today that in conjunction with its annual evaluation process it has issued a total of 125,000 incentive stock options to four directors and one officer of the Company exercisable at $1.21 for a period of five years pursuant to its Stock Option Plan. Its Stock Option Plan has been approved by Shareholders and the TSX Venture Exchange.

About CRH Medical Corporation:

CRH Medical Corporation is utilizing the first single use, patented, disposable, hemorrhoid banding system through its Center for Colorectal Health facilities. According to the National Institute of Health approximately 50% of the U.S. population will develop hemorrhoids by age 50. CRH Medical is opening its Center for Colorectal Health facilities in the United States specializing in the treatment of hemorrhoids, anal fissures, and colon cancer screening and plans to significantly increase the number of Centers for Colorectal Health across the U.S. to address this underserved market. The Company's goal is to become the preeminent resource on colorectal health for consumers and medical professionals in North America .

The information in this news release contains so-called "forward-looking" statements. These include statements regarding CRH Medical's expectations and plans relating to its expansion plans for its Centers for Colorectal Health, statements about CRH Medical's expectations, beliefs, intentions or strategies for the future, which may be indicated by words or phrases such as "anticipate", "expect", "intend", "plan", "will", "we believe", "CRH Medical believes", "management believes", and similar language. All forward-looking statements are based on CRH Medical's current expectations and are subject to risks and uncertainties and to assumptions made. Important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include: (i) the company's ability to successfully recruit medical professionals for its Centers for Colorectal Health (ii) the company's ability to manufacture its products; (iii) decisions, and the timing of decisions, made by the health regulatory agencies regarding the company's products; (iv) the company's ability to enter into distribution agreements for its products, and to complete and maintain corporate alliances relating to the development, commercialization and use of its technology and products; (v) market acceptance of its technologies and products; and (vi) the competitive environment and impact of technological change. CRH Medical bases its forward-looking statements on information currently available to it, and assumes no obligation to update them.

Additional information may also be found by visiting the Company's website at www.crhmedcorp.com or the SEDAR website at www.sedar.com.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

For further information: call Dean Linden, Corporate Communications, CRH Medical Corporation at [phone] or [email protected]